-
Current Clinical Practice
-
Korean J Med. 2014;87(6):686-689. Published online December 1, 2014.
DOI: https://doi.org/10.3904/kjm.2014.87.6.686
- 당뇨병 환자에서 이상지질혈증의 치료
-
김성래
-
가톨릭대학교 의과대학 내분비대사내과
- Dyslipidemia Treatment in Diabetes Mellitus Patients
-
Sung Rae Kijm
-
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
- Corresponding author: Sung Rae Kijm ,Tel: +82-32-340-7013, Fax: +82-32-340-2039, Email: kimsungrae@catholic.ac.kr
-
- Abstract
- Cardiovascular disease (CVD) is the major cause of mortality and morbidity in patients with type 2 diabetes mellitus. The increased risk of CVD in subjects with type 2 diabetes mellitus involves multiple factors, including hypertension, smoking, albuminuria, and hypercholesterolemia. Of these, hypercholesterolemia is amenable to intervention. A large body of research ranging from molecular to population studies indicates that elevated low-density-lipoprotein cholesterol (LDL-C) is a major predictor of CVD, including in the population with diabetes. Despite available therapies and increased attention to hypercholesterolemia, many patients fail to achieve the LDL-C goals. A patient-tailored approach to dyslipidemia therapy, as determined by baseline LDL-C levels, is an effective strategy for achieving target LDL-C levels.
Keywords :Type 2 diabetes mellitus, Cardiovascular disease, Hypercholesterolemia, LDL cholesterol
